Kelly Lamiman
Papers
2
Total Citations
7
H-Index
2
About
Dr. Kelly Lamiman is a rising leader in gynecologic oncology whose research focuses on optimizing surgical approaches for endometrial and ovarian cancers. Her work critically evaluates the role of robotic assistance and minimally invasive techniques in improving patient outcomes. In her landmark 2024 study on type II endometrial cancer, she analyzed a large National Cancer Database cohort to compare conventional laparoscopy with robot-assisted laparoscopy, finding significant implications for surgical practice and overall survival. That paper has already garnered 4 citations, signaling its early impact. Her 2025 investigation into interval complete gross resection for advanced ovarian cancer is equally important, challenging traditional paradigms by comparing laparoscopy versus open surgery after neoadjuvant chemotherapy. With 3 citations to date, this work contributes to the ongoing debate about the safest, most effective debulking strategies. Dr. Lamiman’s contributions are notable for their use of large-scale national data to answer pressing clinical questions, bridging the gap between surgical innovation and evidence-based practice. Her research not only informs surgical decision-making but also shapes future guidelines for women with aggressive gynecologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2